Hygeia Pharmaceuticals Inc. other research news

Hygeia Pharmaceuticals Inc. (VSE:HYG) Hygeia Pharmaceuticals Inc. (VSE:HYG) said that the FDA has requested additional information on its proposed Phase I trial of Monopharm-C, a human monoclonal ant...